Novo Nordisk A/S (NVO) News Today $73.57 -1.76 (-2.34%) Closing price 03/25/2025 03:58 PM EasternExtended Trading$73.68 +0.11 (+0.14%) As of 03/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Novo Nordisk A/S (NYSE:NVO) Sets New 1-Year Low - What's Next?Novo Nordisk A/S (NYSE:NVO) Reaches New 1-Year Low - What's Next?March 26 at 4:25 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Stock Price Down 1.5% - Here's WhyNovo Nordisk A/S (NYSE:NVO) Stock Price Down 1.5% - Time to Sell?March 25 at 2:48 PM | marketbeat.comGrowth Stocks To Follow Now - March 24thNovo Nordisk A/S, Blackstone, BlackRock, Apollo Global Management, Prologis, Welltower, and Incyte are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares in companies that are expected to grow their earnings at an above-average rate compaMarch 25 at 2:09 PM | marketbeat.comHealthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli LillyMarch 25 at 12:59 PM | cnbc.comWoodmont Investment Counsel LLC Purchases 81,163 Shares of Novo Nordisk A/S (NYSE:NVO)Woodmont Investment Counsel LLC boosted its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 276.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 110,551 shares of the company's stock after acquiring an additional 8March 25 at 6:32 AM | marketbeat.comDillon & Associates Inc. Raises Position in Novo Nordisk A/S (NYSE:NVO)Dillon & Associates Inc. grew its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 1.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 287,476 shares of the company's stock after purchasing an additional 4,059 shares during the periodMarch 25 at 6:07 AM | marketbeat.comLPL Financial LLC Sells 6,715 Shares of Novo Nordisk A/S (NYSE:NVO)LPL Financial LLC decreased its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 0.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,356,067 shares of the company's stock after selling 6,715 sMarch 25 at 4:56 AM | marketbeat.comIs Novo Nordisk A/S (NYSE:NVO) The Best Extremely Profitable Stocks to Buy According to Analyst?March 25 at 12:45 AM | insidermonkey.comNovo Nordisk Signs $2B Deal For Obesity Drug With Chinese Biotech: Retail Sentiment ImprovesMarch 24 at 10:06 PM | msn.comNovo Nordisk A/S Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2025 Deadline to file Lead Plaintiff MotionMarch 24 at 7:31 PM | globenewswire.comNovo Nordisk A/S Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights – NVOMarch 24 at 1:45 PM | globenewswire.comWhy Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health PoppedMarch 24 at 12:44 PM | fool.comNovo Nordisk strikes $2 billion deal with a Chinese company making a GLP-1 drugMarch 24 at 12:04 PM | msn.comNovo Nordisk Strikes Up to $2 Billion Licensing Deal for Chinese Firm's Obesity, Diabetes Drug CandidateMarch 24 at 12:04 PM | msn.comNovo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble.March 24 at 10:05 AM | investors.comNovo Nordisk expands discounted Wegovy to all cash-paying US customersMarch 24 at 8:07 AM | reuters.comNovo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offerMarch 24 at 8:00 AM | prnewswire.comNovo Nordisk secures license to weight-loss drug candidate from China's United LabsMarch 24 at 6:21 AM | reuters.comThe United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonistMarch 24 at 6:02 AM | globenewswire.comOptimum Investment Advisors Cuts Position in Novo Nordisk A/S (NYSE:NVO)Optimum Investment Advisors lowered its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 59.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,244 shares of the company's stock after selling 4,750 shares during the quarter. Optimum InvMarch 24 at 5:59 AM | marketbeat.comGuardian Partners Inc. Buys Shares of 127,391 Novo Nordisk A/S (NYSE:NVO)Guardian Partners Inc. bought a new stake in Novo Nordisk A/S (NYSE:NVO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 127,391 shares of the company's stock, valued at approximately $10,910,000. A number oMarch 24 at 5:59 AM | marketbeat.comFortis Capital Management LLC Increases Position in Novo Nordisk A/S (NYSE:NVO)Fortis Capital Management LLC boosted its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 31.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 45,888 shares of the company's stock after acquiring an additional 11,039 shares during the period. Fortis CaMarch 24 at 5:51 AM | marketbeat.comThe Gross Law Firm Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming DeadlineMarch 24 at 5:45 AM | prnewswire.comGermany's SAP overtakes Novo Nordisk as Europe's largest companyMarch 24 at 5:20 AM | reuters.comSei Investments Co. Lowers Stock Position in Novo Nordisk A/S (NYSE:NVO)Sei Investments Co. decreased its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 3.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 640,449 shares of the company's stock after selling 21,303 shaMarch 24 at 5:10 AM | marketbeat.comAmerican Century Companies Inc. Sells 186,802 Shares of Novo Nordisk A/S (NYSE:NVO)American Century Companies Inc. cut its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 12.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,281,161 shares of the company's stock after selling 186,8March 24 at 5:10 AM | marketbeat.comSummit Global Investments Has $818,000 Stake in Novo Nordisk A/S (NYSE:NVO)Summit Global Investments trimmed its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 73.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,513 shares of the company's stock after selling 26,771 shares duringMarch 24 at 4:49 AM | marketbeat.comNovo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sureMarch 24 at 2:36 AM | cnbc.comNovo Nordisk A/S (NYSE:NVO) Receives Average Rating of "Moderate Buy" from AnalystsShares of Novo Nordisk A/S (NYSE:NVO - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the ten analysts that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation aMarch 24 at 2:07 AM | marketbeat.comNVO FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Novo Nordisk A/S Investors to ...March 23 at 4:05 PM | gurufocus.comNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S ...March 23 at 4:05 PM | gurufocus.comNVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitMarch 23 at 4:00 PM | globenewswire.comNVO FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action – NVOMarch 23 at 3:47 PM | globenewswire.comNVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud LawsuitMarch 23 at 9:42 AM | gurufocus.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo NordiskMarch 23 at 9:14 AM | globenewswire.comNVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud LawsuitMarch 23 at 8:12 AM | prnewswire.comAbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market (NVO)Abbvie made an all-time high after announcing an agreement that puts it in the weight loss market; but that just continues a general uptrend in ABBV stockMarch 23 at 7:19 AM | marketbeat.comMarietta Investment Partners LLC Reduces Stock Holdings in Novo Nordisk A/S (NYSE:NVO)Marietta Investment Partners LLC lowered its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 11.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 145,698 shares of the comMarch 23 at 7:03 AM | marketbeat.comGeo Capital Gestora de Recursos Ltd Purchases 43,678 Shares of Novo Nordisk A/S (NYSE:NVO)Geo Capital Gestora de Recursos Ltd grew its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 157.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 71,341 shares of the company's stock after purchasing an additional 43,678 sharesMarch 23 at 6:24 AM | marketbeat.comVirtu Financial LLC Purchases 56,822 Shares of Novo Nordisk A/S (NYSE:NVO)Virtu Financial LLC raised its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 167.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 90,751 shares of the company's stock after acquiring an additionalMarch 23 at 6:08 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Thrivent Financial for LutheransThrivent Financial for Lutherans reduced its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 6.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,635 shares of the comMarch 23 at 4:11 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Cut to Buy at StockNews.comMarch 23 at 1:39 AM | americanbankingnews.comNovo Nordisk A/S (NYSE:NVO) Lowered to Buy Rating by StockNews.comStockNews.com cut Novo Nordisk A/S from a "strong-buy" rating to a "buy" rating in a research report on Friday.March 22, 2025 | marketbeat.comNovo Nordisk (NVO): Among Stocks Wall Street Is Calling Bullish Amid Market TurmoilMarch 22, 2025 | insidermonkey.comNVO Deadline: Rosen Law Firm Urges Novo Nordisk A/S (NYSE: NVO) Stockholders to Contact the Firm for Information About Their RightsMarch 22, 2025 | businesswire.comNovo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design – Hagens BermanMarch 22, 2025 | globenewswire.comNVO DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - NVOMarch 22, 2025 | investing.comNovo Nordisk A/S (NYSE:NVO) Stock Price Down 2% - Should You Sell?Novo Nordisk A/S (NYSE:NVO) Trading Down 2% - Here's What HappenedMarch 21, 2025 | marketbeat.comLevi & Korsinsky Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – NVOMarch 21, 2025 | globenewswire.comNovo Nordisk A/S (NYSE:NVO) Shares Gap Down - Here's WhyNovo Nordisk A/S (NYSE:NVO) Shares Gap Down - Here's What HappenedMarch 21, 2025 | marketbeat.com Remove Ads Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.420.77▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼7838▲NVO Articles Average Week Remove Ads Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today GSK News Today Takeda Pharmaceutical News Today argenx News Today Beigene News Today BioNTech News Today Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
